January 3, 2019SHILAP Revista de lepidopterologíaOpen Access

Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)

View Full Paper

Ask AI

Bookmark

Abstract

ClinicalTrials.gov, NCT02216383 . Registered on 18 August 2014. EudraCT, 2014-001948-37. Registered on 23 September 2014. ISRCTN, ISRCTN10232550. Retrospectively registered on 6 March 2018).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nelson et al. (2019) studied this question.

synapsesocial.com/papers/69d96aa7c7f0c3ae80a3d696 https://doi.org/10.1186/s13063-018-3109-2

View Full Paper

Ask AI

Bookmark

Abstract

ClinicalTrials.gov, NCT02216383 . Registered on 18 August 2014. EudraCT, 2014-001948-37. Registered on 23 September 2014. ISRCTN, ISRCTN10232550. Retrospectively registered on 6 March 2018).

Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)

Abstract

Discussion

Cite This Study

Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)

Abstract

Discussion

Cite This Study

Keep reading

Keep reading